B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

The introduction of clustered enhancing mutations led to complement activation by anti-capsule antibodies for both K.

Harnessing the body's B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern ...

Casitas B-lineage lymphoma b (Cbl/b) is an E3 ubiquitin ligase that has been shown to be a key regulator of the activation of T and natural killer (NK) cells in the absence of CD28 costimulation GRC ...

Proper storage and shipping conditions for cell and gene therapy products are crucial for the design, repeatability, and ...

IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast CancerCasitas B-lineage lymphoma b (Cbl/b) is an E3 ubiquitin ligase ...

Monash University researchers have developed a new technique to boost the effectiveness of both traditional and mRNA-based ...

Monash University researchers have developed a new technique to boost the effectiveness of both traditional and mRNA-based ...